Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age

Urology

Volumn 48, Issue 6 SUPPL., 1996, Pages 55-61

  Partin, Alan W ^a   Catalona, William J ^b   Southwick, Paula C ^c   Subong, Eric N P ^a   Gasior, Gail H ^c   Chan, Daniel W ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Hybritech Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

ADULT; AGE FACTORS; AGED; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0030447621     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00611-5     Document Type: Article

References (23)

1. Christensson A, Laurell CB, and Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 194: 755-763, 1990.
2. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, and Lovgren T: Prostate-specific antigen in human serum occurs predominantly in complex with alpha1-antichymotrypsin. Clin Chem 37: 1618-1625, 1991.
3. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, and Alfthan O: A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer. Assay of the complex improves clinical sensitivity for cancer. Cancer Res 51: 222-226, 1991.
4. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen MT, Cockett ATK, Abrahamsson P, and Lilja H: Serum prostate specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 150: 100-105, 1993.
5. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, and Nadler RB: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274: 1214-1220, 1995.
6. Luderer AA, Chen Y, Soriano TF, Kramp WJ, Carlson B, Cuny C, Sharp T, Smith W, Petteway J, Brawer MK, and Thiel R: Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antgen in the diagnostic gray zone of total prostate-specific antigen. Urology 46: 187-194, 1995.
7. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
8. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, and Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 270: 860-864, 1993.
9. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, and Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324: 1156-1161, 1991.
10. Keetch DW, Catalona WJ, and Smith DS: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 151: 1571-1574, 1994.
11. Terris MK, and Stamey TA: Determination of prostate volume by transrectal ultrasound. J Urol 145: 984-987, 1991.
12. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, and Southwick PC: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290, 1994.
13. Chiacchierini RP: Biostatistics and the analysis of clinical data. Med Device Diagn Ind 18: 49-56, 1996.
14. Turkes A, Nott JP, and Griffiths K: Prostate-specific antigen: problems in analysis. Eur J Cancer 27: 650-652, 1991.
15. Petteway JC, Brawer MK, and Meyer GE: Comparison of two investigative assays for the free form of PSA. J Urol 155: 371A, 1996.
16. Semjonow A, Oberpenning F, Brandt B, and Hertle L: Influence of the free PSA fraction on the measurement of 7 different assays for total PSA. J Urol 155: 420A, 1996.
17. Chen Y, Luderer AA, Thiel RP, Carlson G, Cuny CL, and Soriano TF: Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer. Urology 47: 518-524, 1996.
18. Catalona WJ, Colberg JW, Smith DS, Ornstein DK, and Shayka JJ: Measurement of percent-free PSA improves specificity for lower PSA cutoffs in prostate cancer screening. J Urol 155: 422A, 1996.
19. Oesterling JE, Jacobsen SJ, Klee GG, Pettersson K, Piironen T, Abrahamsson P, Stenman UH, Dowell B, Lovgren T, and Lilja H: Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154: 1090-1095, 1995.
20. Franklin J, Marks LS, Dorey F, Shery ED, deKernion JB, Rhodes T, Partin AW, and Rittenhouse H: Serum PSA levels following TURP in men with BPH: long-term characterization. J Urol 155: 378A, 1996.
21. Prestigiacomo AF, and Stamey TA: Clinical usefulness of free and complexed PSA. Scand J Clin Lab Invest Suppl 221: 32-34, 1995.
22. Klee GG, Lerner SE, Jacobsen SJ, Bergstralh, Lilja H, Pettersson K, Guess HA, Lieber MM, and Oesterling JE: Predictive power of free:total PSA ratio is not superior to total PSA in the diagnosis of prostate cancer in the community setting. J Urol 155: 371A, 1996.
23. Richie JP, Catalona WJ, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, and Southwick PC: Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology 42: 365-374, 1993.